Follow The Filings

UHS Universal Health Services

Health Care, filed as UNIVERSAL HLTH SVCS INC (CL B), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2

  • 3 Owners
  • Max 3.3%
  • $1B
  • 1 add 2 small

In 2026 Q2 Eric Khrom added to Universal Health Services.

Who owns this now

Largest portfolio weights among holders, up to 3.3% (Eric Khrom, Khrom Capital Management). Not free-float ownership.

  1. Eric Khrom Add 3.3%
  2. First Eagle Investment Manage... Add 1.1%
  3. Richard Pzena Add 0.86%

Who owns UHS

Sorted by value, long equity only, as of 2026 Q2.

History
First Eagle Investment Management 1.1% Small add +2.9% 4,554,670 $677M History
Richard Pzena, Pzena Investment Management 0.86% Small add +3.0% 1,969,327 $293M History
Eric Khrom, Khrom Capital Management 3.3%, was 2.8% Add +56.7% 264,994 $39M History

3 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by UHS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All UHS insider trades
  • None no insider bought on the open market
  • $980K sold by 2 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Elliot J Mba Sussman MD Director
    Sale
    $128K 674 shares at $190.06 9.9% of stake
    Traded Mar 11–13 Filed Mar 13
    ↗
  2. Warren J. Nimetz Director
    Sale
    $852K 3,817 shares at $223.30 31% of stake
    Traded Nov 11, 2025 Filed Nov 12, 2025
    ↗
  3. Elliot J Mba Sussman MD Director
    Sale
    $218K 965 shares at $225.70 14% of stake
    Traded Oct 29, 2025 Filed Oct 30, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 22 share withholdings for taxes, 18 other transactions, 15 stock grants, and 10 option exercises.

Congress

2 members of Congress traded UHS in the last three years: 2 buys and 0 sales. 2 members listed it in 2025 annual reports.

All Congress trades
  1. Alan Armstrong R-OK Buy $1K–$15K Mar 27 filed Jul 21
  2. Julia Letlow R-LA-5 Buy $1K–$15K Oct 23, 2025 filed Jan 13

SEC filings

Recent issuer filings from EDGAR, 22 shown.

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
8-K 2.03,8.01,9.01 Filing Doc
424B5 Filing Doc
8-K 1.01,9.01 Filing Doc
424B5 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 5.02 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 5.02 Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 3 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $14.28B $15.83B $17.36B
Net income $0.718B $1.14B $1.49B
Net margin * 5.0% 7.2% 8.6%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $2.81B $2.82B $3.41B
Total non-current assets * $11.16B $11.65B $12.12B
Total assets $13.97B $14.47B $15.53B
Total current liabilities $2.01B $2.21B $3.24B
Total equity $6.15B $6.67B $7.28B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $1.27B $2.07B $1.86B
Cash from investing -$0.763B -$0.911B -$1.07B
Cash from financing -$0.494B -$1.14B -$0.75B
Net change in cash $13.63M $10.28M $46.57M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.